FBTAX | MSVDX | FBTAX / MSVDX | |
Total Expense Ratio | 0.96 | 0.95 | 101% |
Annual Report Gross Expense Ratio | 0.96 | 11.44 | 8% |
Fund Existence | 24 years | 3 years | - |
Gain YTD | -2.573 | -8.262 | 31% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 0 | 1000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.28B | 1.85M | 68,824% |
Annual Yield % from dividends | 3.05 | 0.09 | 3,495% |
Returns for 1 year | -7.14 | -11.40 | 63% |
Returns for 3 years | 45.29 | 1.22 | 3,716% |
Returns for 5 years | -8.77 | N/A | - |
Returns for 10 years | -6.12 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PRHSX | 77.13 | -0.37 | -0.48% |
T. Rowe Price Health Sciences | |||
WFGDX | 10.55 | -0.14 | -1.31% |
Allspring Emerging Growth Admin | |||
FLRAX | 40.05 | -0.58 | -1.43% |
Nuveen Large Cap Select A | |||
LISOX | 15.71 | -0.23 | -1.44% |
Lazard International Strategic Eq Open | |||
GTTTX | 30.35 | -0.55 | -1.78% |
Goldman Sachs Small Cp Val Insghts Inv |